Innovative dual-target drug may lead to new investigational approach for breast cancer patients

Researchers, led by the University of Melbourne’s Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at the Peter Doherty Institute of Infection and Immunity (Doherty Institute), in collaboration

Public Health Experts See More Trouble at CDC as Kennedy Looks To Exert Control

Stephanie Armour The recent firing of former Centers for Disease Control and Prevention director Susan Monarez and the subsequent resignation of four of the agency’s top career officials marks a

New therapy may effectively control HIV in Uganda

A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda. The study,